Thursday, June 2, 2022

Feds Reverse Course On Alzheimer's Drug After Outcry From Down Syndrome Advocates

 Federal officials are backing off a plan that would have kept people with Down syndrome from accessing a new Alzheimer's treatment even though they're predisposed to the disease. Read More >

No comments: